- A brand new GLP-1 remedy demonstrated efficacy in lowering blood sugar in folks with sort 2 diabetes in a part 2b scientific trial.
- Bofanglutide is a biweekly (as soon as each 2 weeks) injection in comparison with once-weekly photographs like Ozempic and Wegovy.
- The brand new biweekly GLP-1 additionally led to weight reduction and enchancment in cardiometabolic danger components.
GLP-1 medication like Ozempic and Wegovy are groundbreaking remedies for sort 2 diabetes and weight problems.
As different drug producers be part of the GLP-1 race, Gan & Lee Prescription drugs in Beijing, China, is creating a novel biweekly GLP-1 for weight reduction.
In a part 2b randomized scientific trial, bofanglutide demonstrated a robust efficacy in lowering blood sugar in folks with sort 2 diabetes.
If authorized, a biweekly shot may supply an alternative choice to once-weekly GLP-1 injections for the needle-averse.
The part 2b scientific trial of bofanglutide included 272 adults with sort 2 diabetes, with a mean age of fifty.8, from 37 websites throughout China. The individuals had been divided into 5 remedy teams:
- bofanglutide 12 mg (biweekly)
- bofanglutide 18 mg (biweekly)
- bofanglutide 24mg (biweekly)
- bofanglutide 24mg (as soon as weekly)
- semaglutide 1mg (as soon as weekly)
The first measurement the researchers targeted on was HbA1c levels from the baseline to the 24-week follow-up.
On the finish of 24 weeks, all bofanglutide teams confirmed vital reductions in blood sugar ranges.
Individuals taking bofanglutide skilled weight reduction and enhancements in varied cardiometabolic danger components.
In some circumstances, blood sugar reductions amongst these taking bofanglutide had been barely higher than these taking semaglutide.
Nevertheless, the semaglutide group obtained a comparatively low dose, highlighting the necessity for additional research.
“Extra real-world comparisons are wanted to find out whether or not this may be more practical than semaglutide,” mentioned Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Middle at Orange Coast Medical Middle in Fountain Valley, CA. Ali wasn’t concerned within the research.
The trial’s findings additionally recommend that bofanglutide may assist handle diabetes and weight problems.
Nevertheless, Clare Thompson, a normal practitioner and lead of the load administration service at Cadogan Clinic in the UK, additional famous the research’s limitations. Thompson wasn’t concerned within the research.
“The research is restricted by its comparatively small measurement and by inhabitants knowledge from a Chinese language cohort, the place the beginning BMI could also be a lot decrease than in Western populations,” she advised Healthline.
“[It] doesn’t present what occurs to sufferers after stopping these medicines or titrating right down to a upkeep dose. Twenty-four weeks is kind of a brief statement interval for drawing full and significant conclusions,” she mentioned.
All GLP-1 medication — semaglutide, bofanglutide, or tirzepatide — could trigger side effects.
Round
Gastrointestinal signs, equivalent to nausea, are among the many most common.
The researchers who performed the trial discovered that whereas these unintended effects could also be extra frequent with bofanglutide, they had been usually gentle.
Different unintended effects could embrace a response on the injection website. This may increasingly embrace swelling, ache or discomfort, discoloration, or a rash.
For those who take a GLP-1 and expertise unintended effects that concern you, communicate along with your healthcare skilled.
